29 Results

People

  1. Landgren
    Landgren
  2. Korde
    Korde
  3. Mailankody
    Mailankody
  4. Hultcrantz
    Hultcrantz
  5. Lesokhin
    Lesokhin
  6. Papaemmanuil
    Papaemmanuil
  7. Yellapantula
    Yellapantula
  8. Giralt
    Giralt
  9. Landau
    Landau
  10. Maura
    Maura

Groups

  1. Center for Hematologic Malignancies (29)
  2. Department of Medicine (29)
  3. Hematologic Malignancies Research (29)
  4. Hematologic Malignancies, Division of (29)
  5. Myeloma (29)
  6. Epidemiology and Biostatistics (12)
  7. Survivorship Research (12)
  8. Sloan Kettering Institute Postdocs (9)
  9. Bone Marrow Transplant (8)
  10. Executive Committee, Center for Hematologic Malignancies (8)
  1. "Hematologic Malignancies, Division of"
  2. "Nature Publishing Group"
  3. "Carl Landgren"
Formats
  1. Journal Article (20)
  2. Research Letter (4)
  3. Meeting Abstract (3)
  4. Review (2)
Groups
  1. Center for Hematologic Malignancies (29)
  2. Department of Medicine (29)
  3. Hematologic Malignancies Research (29)
  4. Hematologic Malignancies, Division of (29)
  5. Myeloma (29)
  6. Epidemiology and Biostatistics (12)

More Groups

People
  1. Carl Landgren (29)
  2. Neha Korde (9)
  3. Sham Mailankody (9)
  4. Alexander Lesokhin (7)
  5. Elli Papaemmanuil (7)
  6. Malin Hultcrantz (7)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (2)
  4. 2020 (6)
  5. 2019 (6)
  6. 2018 (4)

More Years

Publications
  1. Blood Cancer Journal (10)
  2. Bone Marrow Transplantation (6)
  3. Leukemia (4)
  4. Nature Communications (3)
  5. Laboratory Investigation (2)
  6. Clinical Pharmacology & Therapeutics (1)

More Publications

Publishers
  1. Nature Publishing Group (29)

Results (29)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
    Journal Article

    Tan, C. R.; Derkach, A.; Nemirovsky, D.; Ciardiello, A.; Diamond, B.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U.; Maclachlan, K.; more...
    Blood Cancer Journal (2023)

    Fulltext@MSK | Save
  • Nutrition perceptions, needs and practices among patients with plasma cell disorders
    Research Letter

    Malik, M. A.; Sweeney, N. W.; Jafri, M.; Derkach, A.; Chmielewski, C.; Adintori, P. A.; Mailankody, S.; Korde, N.; Tan, C. R.; Hassoun, H.; more...
    Blood Cancer Journal (2022)

    Fulltext@MSK | Save
  • Phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myeloma
    Research Letter

    Lee, H. C.; Raje, N. S.; Landgren, O.; Upreti, V. V.; Wang, J.; Avilion, A. A.; Hu, X.; Rasmussen, E.; Ngarmchamnanrith, G.; Fujii, H.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
    Journal Article

    Boyle, E. M.; Deshpande, S.; Tytarenko, R.; Ashby, C.; Wang, Y.; Bauer, M. A.; Johnson, S. K.; Wardell, C. P.; Thanendrarajan, S.; Zangari, M.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: A randomized, open-label, multicenter, phase 2 study (CENTAURUS)
    Journal Article

    Landgren, C. O.; Chari, A.; Cohen, Y. C.; Spencer, A.; Voorhees, P.; Estell, J. A.; Sandhu, I.; Jenner, M. W.; Williams, C.; Cavo, M.; more...
    Leukemia (2020)

    Fulltext@MSK | Save
  • Accelerated single cell seeding in relapsed multiple myeloma
    Journal Article

    Landau, H. J.; Yellapantula, V.; Diamond, B. T.; Rustad, E. H.; Maclachlan, K. H.; Gundem, G.; Medina-Martinez, J.; Arango Ossa, J.; Levine, M. F.; Zhou, Y.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • B-cell maturation antigen expression across hematologic cancers: A systematic literature review
    Review

    Dogan, A.; Siegel, D.; Tran, N.; Fu, A.; Fowler, J.; Belani, R.; Landgren, O.
    Blood Cancer Journal (2020)

    Fulltext@MSK | Save
  • Baseline VDJ clonotype detection using a targeted sequencing NGS assay: Allowing for subsequent MRD assessment
    Research Letter

    Hultcrantz, M.; Rustad, E. H.; Yellapantula, V.; Arcila, M.; Ho, C.; Syed, M. H.; Papaemmanuil, E.; Zhang, Y.; Maura, F.; Landgren, O.
    Blood Cancer Journal (2020)

    Fulltext@MSK | Save
  • Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma
    Research Letter

    Maura, F.; Rustad, E. H.; Yellapantula, V.; Łuksza, M.; Hoyos, D.; Maclachlan, K. H.; Diamond, B. T.; Greenbaum, B. D.; Morgan, G.; Lesokhin, A.; more...
    Leukemia (2020)

    Fulltext@MSK | Save
  • Timing the initiation of multiple myeloma
    Journal Article

    Rustad, E. H.; Yellapantula, V.; Leongamornlert, D.; Bolli, N.; Ledergor, G.; Nadeu, F.; Angelopoulos, N.; Dawson, K. J.; Mitchell, T. J.; Osborne, R. J.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save